Derakhshan Marzieh, Salehi Peyman, Derakhshan Maryam, Naghshineh Elham, Movahedi Minoo, Tehrani Hatav Ghasemi, Salehi Ensieh
Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Anatomical Sciences, Shahid Beheshti Fertility Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Clin Exp Reprod Med. 2025 Sep;52(3):268-274. doi: 10.5653/cerm.2024.07276. Epub 2024 Dec 11.
The choice between utilizing testicular or ejaculatory sperm for intracytoplasmic sperm injection (ICSI) in men with severe oligozoospermia or cryptozoospermia is a crucial aspect of managing male infertility. This study aimed to identify a predictive factor that could guide this decision-making process.
Seventy-five infertile men with severe oligozoospermia or cryptozoospermia were included in the analysis. On the day of ovum pick-up, these participants were divided into three groups (n=25 each) based on their sperm concentrations: cryptozoospermia, 0.1-1 million/mL and 1-5 million/mL. Patients in each group underwent ICSI, which involved the insemination of sibling oocytes using either ejaculated spermatozoa or testicular spermatozoa obtained via fine-needle aspiration. We evaluated the rates of fertilization, cleavage, high-quality embryo production, and blastocyst formation.
In patients with sperm concentrations below 1 million/mL, testicular sperm demonstrated higher rates of fertilization (p<0.001), cleavage (p=0.01), high-quality embryo formation (p=0.003), and blastocyst development (p=0.04) compared to ejaculated sperm. In cases of cryptozoospermia, testicular sperm was associated with a higher fertilization rate (p<0.001) and a marginally higher rate of high-quality embryos (p=0.06). Conversely, in patients with sperm concentrations exceeding 1 million/mL, ejaculated sperm yielded superior outcomes.
This study underscores the significance of considering sperm concentration when advising on sperm retrieval techniques to improve ICSI outcomes in men diagnosed with severe oligozoospermia or cryptozoospermia. Further research is necessary to confirm predictive factors that assist in decision-making regarding the source of sperm, whether from ejaculate, testicular aspiration, or biopsies.
对于严重少精子症或隐匿精子症男性,在进行卵胞浆内单精子注射(ICSI)时选择使用睾丸精子还是射精精子是男性不育治疗中的一个关键问题。本研究旨在确定一个能够指导这一决策过程的预测因素。
75例严重少精子症或隐匿精子症的不育男性纳入分析。在取卵日,根据精子浓度将这些参与者分为三组(每组n = 25):隐匿精子症组、0.1 - 100万/mL组和100 - 500万/mL组。每组患者均接受ICSI,即使用射出的精子或通过细针抽吸获得的睾丸精子对同胞卵母细胞进行授精。我们评估了受精率、卵裂率、优质胚胎形成率和囊胚形成率。
精子浓度低于100万/mL的患者中,与射出精子相比,睾丸精子的受精率(p < 0.001)、卵裂率(p = 0.01)、优质胚胎形成率(p = 0.003)和囊胚发育率(p = 0.04)更高。在隐匿精子症病例中,睾丸精子的受精率更高(p < 0.001),优质胚胎率略高(p = 0.06)。相反,精子浓度超过100万/mL的患者,射出精子产生的结果更好。
本研究强调了在为诊断为严重少精子症或隐匿精子症的男性建议精子获取技术时,考虑精子浓度对改善ICSI结果的重要性。需要进一步研究以确认有助于就精子来源(无论是射出精子、睾丸抽吸还是活检)做出决策的预测因素。